Clinical Chemistry and Immunoassay Industry, Global, 2023?2028

Healthcare Clinical Chemistry and Immunoassay Industry, Global, 2023?2028

Integrated and Scalable Core Lab Solutions Driving Transformational Growth

INDUSTRY
Healthcare

RELEASE DATE
30-Oct-2024
REGION
Global
DELIVERABLE TYPE
Market Research

RESEARCH CODE
PFPY-01-00-00-00
SKU
HC_2024_1106
Yes
SHARE

$4,950.00

Special Price $4,207.50 save 15 %

In stock
SKU
HC_2024_1106

Clinical Chemistry and Immunoassay Industry, Global, 2023?2028
Published on: 30-Oct-2024 | SKU: HC_2024_1106

Need more details?

$4,950.00

$4,207.50 save 15 %

DownloadLink
Need more details?

This analysis examines the global clinical chemistry and immunoassay sector, accounting for the highest share in the in vitro diagnostics (IVD) market. This type of lab-based testing analyzes body fluids (usually blood, urine, or saliva) using integrated/standalone analyzers and a wide range of assays/panels, among other solutions and services to support the diagnosis and treatment of human health.

While clinical chemistry instruments and tests target different chemicals in body fluids to evaluate health and the clinical management of patients, immunoassay instruments and tests measure the presence or concentration of analytes in biological liquid by using the binding of antibodies to antigens to identify and measure certain substances. This competitive analysis examines IVD companies that provide a broad menu of clinical chemistry and immunoassay systems, including instruments and consumables. Key end-user verticals comprise hospitals, clinics, diagnostic laboratories, and research institutions. The sector is segmented by applications, including cancer/oncology, cardiac, diabetes, infectious, and others, for market revenue estimations and forecasts. The study also identifies four growth opportunities that build on trends, maximize the economic potential, and sustain value.

Author: Amartya Bose

Scope of Analysis

Segmentation

Why Is It Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the Clinical Chemistry and Immunoassay Industry

Competitive Environment

Key Competitors

Growth Metrics

Growth Drivers

Growth Drivers (continued)

Growth Restraints

Forecast Considerations

Revenue Forecast

Revenue Forecast by Application Areas

Revenue Forecast by Region

Revenue Forecast Analysis

Pricing Trends and Forecast Analysis

Revenue Share

Revenue Share Analysis

Revenue Share Analysis (continued)

Growth Metrics

Revenue Forecast

Revenue Forecast by Region

Forecast Analysis

Growth Metrics

Revenue Forecast

Revenue Forecast by Region

Forecast Analysis

Growth Metrics

Revenue Forecast

Revenue Forecast by Region

Forecast Analysis

Growth Metrics

Revenue Forecast

Revenue Forecast by Region

Forecast Analysis

Growth Metrics

Revenue Forecast

Revenue Forecast by Region

Forecast Analysis

Growth Opportunity 1: Sepsis IVDs

Growth Opportunity 1: Sepsis IVDs (continued)

Growth Opportunity 2: Neurology IVDs

Growth Opportunity 2: Neurology IVDs (continued)

Growth Opportunity 3: Routine Testing

Growth Opportunity 3: Routine Testing (continued)

Growth Opportunity 4: Integrated Analyzers

Growth Opportunity 4: Integrated Analyzers (continued)

Benefits and Impacts of Growth Opportunities

Next Steps

List of Exhibits

List of Exhibits (continued)

Legal Disclaimer

List of Figures
  • Clinical Chemistry and Immunoassay: Growth Metrics, Global, 2023‒2028
  • Clinical Chemistry and Immunoassay: Growth Drivers, Global, 2024-2028
  • Clinical Chemistry and Immunoassay: Growth Restraints, Global, 2024-2028
  • Clinical Chemistry and Immunoassay: Revenue Forecast, Global, 2023‒2028
  • Clinical Chemistry and Immunoassay: Revenue Forecast by Application Areas, Global, 2023-2028
  • Clinical Chemistry and Immunoassay: Revenue Forecast by Region, 2023-2028
  • Clinical Chemistry and Immunoassay: Revenue Share of Top Participants, Global, 2023
  • Cancer: Growth Metrics, Global, 2023
  • Cancer: Revenue Forecast, Global, 2023-2028
  • Cancer: Revenue Forecast by Region, 2023-2028
  • Cardiac: Growth Metrics, Global, 2023
  • Cardiac: Revenue Forecast, Global, 2023-2028
  • Cardiac: Revenue Forecast by Region, 2023-2028
  • Diabetes: Growth Metrics, Global, 2023
  • Diabetes: Revenue Forecast, Global, 2023-2028
  • Diabetes: Revenue Forecast by Region, 2023-2028
  • Infectious Diseases: Growth Metrics, Global, 2023-2028
  • Infectious Diseases: Revenue Forecast, Global, 2023-2028
  • Infectious Diseases: Revenue Forecast by Region, 2023-2028
  • Others: Growth Metrics, Global, 2023-2028
  • Others: Revenue Forecast, Global, 2023-2028
  • Others: Revenue Forecast by Region, 2023-2028

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

06 Aug 2026   |   Global   |   Technology Research

Decentralized Clinical Trials Powered by Blockchain and Digital Twins

This report examines how decentralized clinical trials (DCTs), enabled by blockchain, digital twins, and artificial intelligence, are reshaping global clinical research. It traces the shift from site-centric to patient-centric models and quantifies the growing scale, globalization, and complexity of...

04 Aug 2026   |   Global   |   Market Research

Global Capnography Devices Market, Forecast to 2031

The capnography market is undergoing a significant transformation from its traditional role in anesthesia and intensive care monitoring to a broader, continuous respiratory surveillance ecosystem. This evolution is being driven by increasing integration of capnography into multiparameter monitoring ...

31 Jul 2026   |   Global   |   Market Research

Growth Opportunities in Small-Molecule Contract Development and Manufacturing Organizations, Global, 2026–2031

The global small‑molecule CDMO industry is undergoing a structural transformation driven by increasing molecular complexity, patent expiries, cost pressures, and the strategic need to secure resilient pharmaceutical supply chains. Demand is shifting beyond high‑volume commodity generics toward s...

30 Jul 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Wearables and Drug Delivery Solutions

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, wearables and drug delivery solutions.

The issue features advanced medical devices such as non-invasive bimoda...

30 Jul 2026   |   Global   |   Frost Radar

Frost Radar™: Life Sciences Regulatory Information Management Platforms, 2026

The regulatory technology market in life sciences has, over the last five years, quietly transformed from a back-office category dominated by document repositories and submission publishing tools to one of the most consequential software segments serving the pharmaceutical, biotech, and medical devi...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

This analysis examines the global clinical chemistry and immunoassay sector, accounting for the highest share in the in vitro diagnostics (IVD) market. This type of lab-based testing analyzes body fluids (usually blood, urine, or saliva) using integrated/standalone analyzers and a wide range of assays/panels, among other solutions and services to support the diagnosis and treatment of human health. While clinical chemistry instruments and tests target different chemicals in body fluids to evaluate health and the clinical management of patients, immunoassay instruments and tests measure the presence or concentration of analytes in biological liquid by using the binding of antibodies to antigens to identify and measure certain substances. This competitive analysis examines IVD companies that provide a broad menu of clinical chemistry and immunoassay systems, including instruments and consumables. Key end-user verticals comprise hospitals, clinics, diagnostic laboratories, and research institutions. The sector is segmented by applications, including cancer/oncology, cardiac, diabetes, infectious, and others, for market revenue estimations and forecasts. The study also identifies four growth opportunities that build on trends, maximize the economic potential, and sustain value. Author: Amartya Bose
More Information
Deliverable Type Market Research
Author Amartya Bose
Industries Healthcare
No Index No
Is Prebook No
Keyword 1 Clinical Chemistry Market
Keyword 2 Global Diagnostics Growth
Keyword 3 Healthcare Technologies
List of Charts and Figures Clinical Chemistry and Immunoassay: Growth Metrics, Global, 2023‒2028~ Clinical Chemistry and Immunoassay: Growth Drivers, Global, 2024-2028~ Clinical Chemistry and Immunoassay: Growth Restraints, Global, 2024-2028~ Clinical Chemistry and Immunoassay: Revenue Forecast, Global, 2023‒2028~ Clinical Chemistry and Immunoassay: Revenue Forecast by Application Areas, Global, 2023-2028~ Clinical Chemistry and Immunoassay: Revenue Forecast by Region, 2023-2028~ Clinical Chemistry and Immunoassay: Revenue Share of Top Participants, Global, 2023~ Cancer: Growth Metrics, Global, 2023~ Cancer: Revenue Forecast, Global, 2023-2028~ Cancer: Revenue Forecast by Region, 2023-2028~ Cardiac: Growth Metrics, Global, 2023~ Cardiac: Revenue Forecast, Global, 2023-2028~ Cardiac: Revenue Forecast by Region, 2023-2028~ Diabetes: Growth Metrics, Global, 2023~ Diabetes: Revenue Forecast, Global, 2023-2028~ Diabetes: Revenue Forecast by Region, 2023-2028~ Infectious Diseases: Growth Metrics, Global, 2023-2028~ Infectious Diseases: Revenue Forecast, Global, 2023-2028~ Infectious Diseases: Revenue Forecast by Region, 2023-2028~ Others: Growth Metrics, Global, 2023-2028~ Others: Revenue Forecast, Global, 2023-2028~ Others: Revenue Forecast by Region, 2023-2028~
Podcast No
WIP Number PFPY-01-00-00-00